arrow
T

Takayuki Ohkuri

department of pathology
H指数:25
被引数:3,041

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-associated antigen-reactive T cells and clinical outcomes in head and neck squamous cell carcinoma treated with pembrolizumab plus chemotherapy

头颈部鳞状细胞癌患者接受帕博利珠单抗联合化疗治疗后,肿瘤相关抗原反应性T细胞与临床结局的关系

2026-08-240
OA
Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study

Nivolumab治疗胸膜间皮瘤中肿瘤细胞VISTA表达对生存结局的预后意义:HOT1901回顾性多中心研究

2026-08-170
OA
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1-Mutant Lung Cancer

二肽基肽酶4修复促进KRAS-LKB1突变型肺癌的抗肿瘤免疫

2025-12-010
PRE
Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer
2021-09-183
OA
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
2020-12-2916
OAAI
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

PD-L1-specific辅助性T细胞表现出有效的抗肿瘤反应: 靶向头颈部鳞状细胞癌PD-L1的癌症免疫治疗新策略

2019-06-2012
OAAI
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy

表观遗传修饰增强了人类白细胞抗原G作为基于T细胞的免疫疗法的肿瘤抗原的免疫原性

2016-03-3033
OAAI